XML 16 R4.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating expenses:    
Research and development $ 11,814 $ 6,603
General and administrative 5,025 4,369
Total operating expenses 16,839 10,972
Loss from operations (16,839) (10,972)
Other income (expense):    
Interest income 60 63
Other expenses (105) (141)
Other expenses, net (45) (78)
Net loss (16,884) (11,050)
Other comprehensive (loss) income:    
Unrealized (losses) gains on available-for-sale securities (132) 10
Foreign currency translation adjustment (15)
Total other comprehensive (loss) income (147) 10
Comprehensive loss (17,031) (11,040)
Net loss attributable to common stockholders—basic and diluted $ (16,884) $ (11,050)
Net loss per share attributable to common stockholders—basic and diluted $ (0.71) $ (0.47)
Weighted-average common shares outstanding—basic and diluted 23,686,351 23,429,507